Displaying drugs 6576 - 6600 of 6772 in total
Elacytarabine
Elacytarabine is a fatty acid derivative of cytarabine, an approved cytotoxic cancer drug. Cytarabine has limitations such as minimal uptake in solid tumours and is only used to treat leukaemia. Elacytarabine is designed to overcome this limitation and has shown considerable uptake in solid tumour cells. Elacytarabine is a patented...
Investigational
Daglutril
Daglutril is an orally active, mixed neutral endopeptidase/endothelin converting enzyme inhibitor under development for the treatment of essential hypertension and congestive heart failure.
Investigational
AGN-201904
Agn 201904 has been used in trials studying the prevention of Peptic Ulcer.
Investigational
Penamecillin
Experimental
Raceanisodamine
Investigational
Calyculin A
Experimental
Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline
Experimental
Iodoxamic acid
Radiopaque medium used in the diagnosis of gall bladder & bile duct diseases, usually as meglumine salt.
Experimental
Ioglycamic acid
Experimental
Uridine-5'-Diphosphate
A uracil nucleotide containing a pyrophosphate group esterified to C5 of the sugar moiety. [PubChem]
Experimental
Uridine monophosphate
5'-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position.
Experimental
TMP
Experimental
2'-O-butyl-5-methyluridine
Experimental
Adenosine-5'-diphosphate-2',3'-vanadate
Experimental
RPR131247
Experimental
Laniquidar
Laniquidar has been used in trials studying the treatment of Breast Cancer.
Investigational
Denufosol
Denufosol was an inhaled drug used for the treatment of cystic fibrosis (CF), showing various improvements in lung function during a phase III clinical trial. A new drug application (NDA) was filed with the FDA in 2011, however, the second phase III clinical trial showed a lack of improvement in...
Investigational
Ceftezole
Experimental
Displaying drugs 6576 - 6600 of 6772 in total